2015
DOI: 10.1016/j.psychres.2014.09.005
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological blockade of memory reconsolidation in posttraumatic stress disorder: Three negative psychophysiological studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
128
1
3

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 160 publications
(133 citation statements)
references
References 33 publications
1
128
1
3
Order By: Relevance
“…Increased salience network connectivity has also been documented in a host of anxiety disorders, notably including PTSD (Peterson et al, 2014). Furthermore, propranolol-another pharmacological agent investigated as an adjunct for PTSD therapy (Brunet et al, 2008, but see Wood et al, 2015;Steenen et al, 2016)-decreases connectivity within the salience network (Hermans et al, 2011). Thus, it is worth considering whether action at the salience network might be an important component of the mechanism by which MDMA operates in MDMA-assisted psychotherapy for PTSD (Mithoefer et al, 2011;Mithoefer et al, 2012;Oehen et al, 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Increased salience network connectivity has also been documented in a host of anxiety disorders, notably including PTSD (Peterson et al, 2014). Furthermore, propranolol-another pharmacological agent investigated as an adjunct for PTSD therapy (Brunet et al, 2008, but see Wood et al, 2015;Steenen et al, 2016)-decreases connectivity within the salience network (Hermans et al, 2011). Thus, it is worth considering whether action at the salience network might be an important component of the mechanism by which MDMA operates in MDMA-assisted psychotherapy for PTSD (Mithoefer et al, 2011;Mithoefer et al, 2012;Oehen et al, 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Drug craving (Xue et al 2012;Saladin et al 2013) and PTSD (Brunet et al 2008;Menzies 2012) are two clinical conditions, in which it has been reported that targeting their underlying maintaining mechanisms through reconsolidation can lead to some clinical improvement . However, the results of other studies indicate that the practical usefulness of blocking reconsolidation in the treatment of trauma requires further exploration Wood et al 2015). containing N-methyl-D-aspartate (NMDA) receptors are activated for the memory to go from a consolidated inactive state (IS) to a labile active state (AS) (gray curved arrow).…”
Section: Potential Clinical Implicationsmentioning
confidence: 99%
“…Golkar, Bellander, Olsson, & Öhman, 2012; Hardwicke, Taqi, & Shanks, 2016; Kindt & Soeter, 2013; Soeter & Kindt, 2011; Wichert et al, 2011) or pharmacological manipulations (e.g. Bos, Beckers, & Kindt, 2014; Wood et al, 2015). The study of Hardwicke et al (2016) makes a particularly strong case against reconsolidation effects in humans, because it attempted to directly and conceptually replicate the results of a study that has been frequently referred to as a convincing demonstration of human reconsolidation in procedural memory (Walker, Brakefield, Hobson, & Stickgold, 2003), but was unsuccessful in seven experiments.…”
Section: Discussionmentioning
confidence: 99%
“…which may manifest itself as less intrusions in PTSD). Focusing on novel behavioural interventions is especially important, because recent studies show that frequently used pharmacological agents do not consistently affect reconsolidation in patients and healthy participants (Wood et al, 2015; for a meta-analysis see Lonergan, Olivera-Figueroa, Pitman, & Brunet, 2013). Given the potential of reconsolidation manipulations in psychological treatments, an important question is whether changing memories during reconsolidation by use of behavioural manipulations is a finding that can be replicated reliably.…”
mentioning
confidence: 99%